Meanwhile, Madrigal told PEOPLE on Sunday that “we shall see” if season 12, with its fresh faces, will rival the drama from seasons 1 and 2. “I think it’s got the potentia ...
Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were sinking 13.3% lower as of 11:11 a.m. ET on Monday. The sell-off came after the drugmaker announced its preliminary fourth-quarter and full ...
Madrigal Pharmaceuticals stock retreated Monday after the company shared its preliminary earnings for 2024. Shares fell 16% to $285.19. They are up about 18% over the past 12 months.